Regulators approve the first cancer-killing virus, Nature Reviews Drug Discovery, vol.14, p.811, 2015. ,
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma, J Clin Oncol, vol.33, issue.25, p.26014293, 2015. ,
Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy, Mol Ther, vol.22, issue.1, p.3978812, 2014. ,
Oncolytic viruses: a new class of immunotherapy drugs, Nat Rev Drug Discov, vol.14, issue.9, pp.642-62, 2015. ,
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production, Proc Natl Acad Sci, vol.107, issue.4, p.2824402, 2010. ,
Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin, Cancer Res, vol.70, issue.2, pp.598-608, 2010. ,
Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication, Int J Cancer, vol.129, issue.6, p.3133790, 2011. ,
The ever-evolving role of mTOR in translation, Semin Cell Dev Biol, vol.36, p.25263010, 2014. ,
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)KmTOR-p70S6K pathway, Nat Immunol, vol.9, issue.10, p.3732485, 2008. ,
Akt and mRNA translation by interferons, Cell Cycle, vol.7, issue.14, p.18635959, 2008. ,
Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)-and ribosomal protein S6K-mediated signals, Mol Cell Biol, vol.29, issue.10, p.2682034, 2009. ,
S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3, Nat Immunol, vol.17, issue.5, pp.514-536, 2016. ,
, PLOS Pathogens |, 2018.
Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling, J Biol Chem, vol.282, issue.3, p.17114181, 2006. ,
Translational control of the innate immune response through IRF-7, Nature, vol.452, issue.7185, pp.323-331, 2008. ,
Deficiency in either 4E-BP1 or 4E-BP2 augments innate antiviral immune responses, PLoS One, vol.9, issue.12, p.4273997, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01198954
Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation, Nat Immunol, vol.16, issue.8, p.4509841, 2015. ,
Battling for Ribosomes: Translational Control at the Forefront of the Antiviral Response, J Mol Biol, vol.430, issue.14, p.29746850, 2018. ,
The mechanism of eukaryotic translation initiation and principles of its regulation, Nat Rev Mol Cell Biol, vol.11, issue.2, p.4461372, 2010. ,
Hierarchical phosphorylation of the translation inhibitor 4E-BP1, Genes Dev, vol.15, issue.21, p.312813, 2001. ,
Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3, Nat Commun, vol.7, p.4915159, 2016. ,
Targeting the translation machinery in cancer, Nat Rev Drug Discov, vol.14, issue.4, pp.261-78, 2015. ,
Rapamycin passes the torch: a new generation of mTOR inhibitors, Nat Rev Drug Discov, vol.10, issue.11, pp.868-80, 2011. ,
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies, Cancer Res, vol.72, issue.24, pp.6468-76, 2012. ,
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells, Oncotarget, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01350841
, , vol.8, p.28881582, 2016.
, , p.5584165
Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication, Genes Dev, vol.24, issue.23, p.21123650, 2010. ,
, , p.2994037
Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication, J Virol, vol.84, issue.10, p.2863801, 2010. ,
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo, Mol Ther, vol.16, issue.1, p.17998900, 2008. ,
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide, Clin Cancer Res, vol.15, issue.8, pp.2777-88, 2009. ,
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin, Cancer Res, vol.67, issue.18, p.17875723, 2007. ,
mTOR Signaling in Growth, Metabolism, and Disease, Cell, vol.169, issue.2, p.28388417, 2017. ,
IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma, Cell Death Differ, vol.7, issue.7, pp.654-65, 2000. ,
, PLOS Pathogens |, 2018.
Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties, Prog Clin Biol Res, vol.271, pp.265-76, 1988. ,
Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development, Mol Cell Biol, vol.27, issue.18, p.2099621, 2007. ,
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients, Clin Cancer Res, vol.23, issue.14, p.28495911, 2017. ,
Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses, Proc Natl Acad Sci U S A, vol.109, issue.20, p.22550181, 2012. ,
, , p.3356630
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2, PLoS Biol, vol.7, issue.2, 2009. ,
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs, Science, vol.328, issue.5982, p.2893390, 2010. ,
nanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs ,
, Genome Res, vol.26, issue.5, p.4864462, 2016.
Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma, Am J Cancer Res, vol.6, issue.2, p.4859661, 2016. ,
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas, Haematologica, vol.102, issue.4, p.5395116, 2017. ,
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap, Nature, vol.345, issue.6275, pp.544-551, 1990. ,
Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma, Oncotarget, vol.8, issue.38, p.5609906, 2017. ,
Translational homeostasis via the mRNA cap-binding protein, eIF4E, Mol Cell, vol.46, issue.6, p.4085128, 2012. ,
4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications, Cancer Res, vol.67, issue.16, p.17699757, 2007. ,
Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells, Oncogene, vol.35, p.26257065, 2016. ,
Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy, Cancer Immunol Res, vol.1, issue.5, pp.309-328, 2013. ,
The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma, Mol Ther, vol.12, issue.6, 2005. ,
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy, PLOS Pathogens, vol.48, issue.6, p.28886381, 2017. ,
Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy, Front Oncol, vol.7, p.5459877, 2017. ,
Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor, Genes Dev, vol.26, issue.14, p.3404381, 2012. ,
Herpes simplex virus in solid organ transplantation, Am J Transplant, vol.13, p.23465005, 2013. ,
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines, Cancer Cell, vol.33, issue.4, p.29634947, 2018. ,
MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1, Cell Rep, vol.18, issue.6, p.5321627, 2017. ,
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming, Genes Dev, vol.31, issue.22, p.5769768, 2017. ,
mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation, Cell Metab, vol.18, issue.5, p.24206664, 2013. ,
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin Chem, vol.55, issue.4, p.19246619, 2009. ,
A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines, Methods, vol.50, issue.4, p.20215014, 2010. ,
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale, J Vis Exp, issue.87, 2014. ,